BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30349541)

  • 1. Regulation of Lymphatic GM-CSF Expression by the E3 Ubiquitin Ligase Cbl-b.
    Peer S; Cappellano G; Hermann-Kleiter N; Albrecht-Schgoer K; Hinterleitner R; Baier G; Gruber T
    Front Immunol; 2018; 9():2311. PubMed ID: 30349541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction.
    Duncker PC; Stoolman JS; Huber AK; Segal BM
    J Immunol; 2018 Feb; 200(3):966-973. PubMed ID: 29288202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
    Hoyne GF; Flening E; Yabas M; Teh C; Altin JA; Randall K; Thien CB; Langdon WY; Goodnow CC
    J Immunol; 2011 Feb; 186(4):2024-32. PubMed ID: 21248249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
    Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
    J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease.
    Pierson ER; Goverman JM
    JCI Insight; 2017 Apr; 2(7):e92362. PubMed ID: 28405624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
    Yoshimura S; Thome R; Konno S; Mari ER; Rasouli J; Hwang D; Boehm A; Li Y; Zhang GX; Ciric B; Rostami A
    J Immunol; 2020 Feb; 204(3):531-539. PubMed ID: 31852750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
    Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
    J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome-derived IL-1β regulates the production of GM-CSF by CD4(+) T cells and γδ T cells.
    Lukens JR; Barr MJ; Chaplin DD; Chi H; Kanneganti TD
    J Immunol; 2012 Apr; 188(7):3107-15. PubMed ID: 22345669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function.
    Stürner KH; Borgmeyer U; Schulze C; Pless O; Martin R
    J Immunol; 2014 Nov; 193(9):4439-47. PubMed ID: 25261476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
    Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
    J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
    Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
    J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
    Fujiwara M; Anstadt EJ; Khanna KM; Clark RB
    Clin Immunol; 2015 May; 158(1):103-13. PubMed ID: 25829233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation.
    Sheng W; Yang F; Zhou Y; Yang H; Low PY; Kemeny DM; Tan P; Moh A; Kaplan MH; Zhang Y; Fu XY
    Cell Res; 2014 Dec; 24(12):1387-402. PubMed ID: 25412660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.
    El-Behi M; Ciric B; Dai H; Yan Y; Cullimore M; Safavi F; Zhang GX; Dittel BN; Rostami A
    Nat Immunol; 2011 Jun; 12(6):568-75. PubMed ID: 21516111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis.
    Ponomarev ED; Shriver LP; Maresz K; Pedras-Vasconcelos J; Verthelyi D; Dittel BN
    J Immunol; 2007 Jan; 178(1):39-48. PubMed ID: 17182538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 expression on CD34(+) hemopoietic progenitors induced by granulocyte-macrophage colony-stimulating factor: II. Signaling pathways involved.
    Jinquan T; Anting L; Jacobi HH; Glue C; Jing C; Ryder LP; Madsen HO; Svejgaard A; Skov PS; Malling HJ; Poulsen LK
    J Immunol; 2001 Oct; 167(8):4405-13. PubMed ID: 11591765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells.
    Poppensieker K; Otte DM; Schürmann B; Limmer A; Dresing P; Drews E; Schumak B; Klotz L; Raasch J; Mildner A; Waisman A; Scheu S; Knolle P; Förster I; Prinz M; Maier W; Zimmer A; Alferink J
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3897-902. PubMed ID: 22355103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.
    Uyttenhove C; Gaignage M; Donckers D; Nasr Z; Cheou P; van Snick J; D'Auria L; van Pesch V
    Eur J Immunol; 2018 Nov; 48(11):1883-1891. PubMed ID: 30216414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th Cells.
    Rasouli J; Casella G; Ishikawa LLW; Thome R; Boehm A; Ertel A; Melo-Silva CR; Mari ER; Porazzi P; Zhang W; Xiao D; Sigal LJ; Fortina P; Zhang GX; Rostami A; Ciric B
    Front Immunol; 2021; 12():679498. PubMed ID: 34149716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing the expression of Cbl-b enhances the immune activation of T lymphocytes against RM-1 prostate cancer cells in vitro.
    Zhou SK; Chen WH; Shi ZD; Wang SP; Li L; Wen XF; Wang YM
    J Chin Med Assoc; 2014 Dec; 77(12):630-6. PubMed ID: 25249301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.